News & Topics

We developed “dopasomes,” liposomal nanoparticles cross-linked within the membrane by dopamine self-polymerization, which shows greatly improved stability over conventional liposomes and offers a promising platform for next-generation lipid-based drug-delivery systems.

We have developed a method for introducing hydrophobic compounds including anticancer agents into extracellular vesicles without using organic solvents or physical stimuli.